Strategic IP Support since 1997


Recent Insights & News

Owning It Is Not Controlling It

October was a month about the gap between owning a right and controlling an outcome. A valid patent on a drug’s mechanism that left its owner with no market. A licence signed years ago that now decides which defence contracts a company may bid for. A US$4.7 trillion profit shift that goes to whoever holds…

Who sets the price of your IP? Why the licence decides, not the patent

The patent is rarely where the money is decided. The licence is. Three IP developments from the past week make that point, and each turns on terms settled, or left unsettled, long before anyone reached a court. In the United Kingdom, the government has published its response to its consultation on standard essential patents, the…